Treating Mental Illness with Psychedelics

When we started studying LSD and mescaline, our long-term goal was to increase our understanding of schizophrenia and what it does. We first examined the psychotomimetic properties of LSD on normal subjects. We never knowingly gave it to schizophrenic patients or to their first-order relatives. Our personal experience and seeing its effect on many normal subjects gave us a good deal of information of what it is like to be psychotic, but in a controlled setting and knowing that it would pass. Continue Reading >>